resistant tuberculosis Archives

Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

Biotech Pharma

FDA approves new drug for one of the deadliest forms of drug resistant tuberculosis

September 11, 2019 3470 Views

Pretomanid, developed by the non-profit TB Alliance, has received U.S. approval for people with XDR-TB or treatment-intolerant/non-responsive MDR-TB. ...